BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 14512435)

  • 1. Hypothalamic-pituitary cytokine network.
    Kariagina A; Romanenko D; Ren SG; Chesnokova V
    Endocrinology; 2004 Jan; 145(1):104-12. PubMed ID: 14512435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
    Chesnokova V; Kariagina A; Melmed S
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1110-8. PubMed ID: 11934677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
    Chesnokova V; Melmed S
    Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
    Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
    Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia inhibitory factor signaling is implicated in embrionic development of the HPA axis.
    Ware CB; Kariagina A; Zonis S; Alon D; Chesnokova V
    FEBS Lett; 2005 Aug; 579(20):4465-9. PubMed ID: 16081071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Chesnokova V; Melmed S
    Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Melmed S
    Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
    Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.
    Chesnokova V; Auernhammer CJ; Melmed S
    Endocrinology; 1998 May; 139(5):2209-16. PubMed ID: 9564824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
    Ray DW; Ren SG; Melmed S
    J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental exposure to corticosterone: behavioral changes and differential effects on leukemia inhibitory factor (LIF) and corticotropin-releasing hormone (CRH) gene expression in the mouse.
    Pechnick RN; Kariagina A; Hartvig E; Bresee CJ; Poland RE; Chesnokova VM
    Psychopharmacology (Berl); 2006 Mar; 185(1):76-83. PubMed ID: 16416158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C; Zatelli MC; Melmed S
    J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia inhibitory factor regulates proopiomelanocortin transcription.
    Ray DW; Ren SG; Melmed S
    Ann N Y Acad Sci; 1998 May; 840():162-73. PubMed ID: 9629248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing hormone regulates IL-6 expression during inflammation.
    Venihaki M; Dikkes P; Carrigan A; Karalis KP
    J Clin Invest; 2001 Oct; 108(8):1159-66. PubMed ID: 11602623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function.
    Akita S; Conn PM; Melmed S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4170-8. PubMed ID: 8923879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion.
    Akita S; Malkin J; Melmed S
    Endocrinology; 1996 Jul; 137(7):3140-3. PubMed ID: 8770940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.
    Shimon I; Yan X; Ray DW; Melmed S
    J Clin Invest; 1997 Jul; 100(2):357-63. PubMed ID: 9218512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interleukin 1beta on the HPA axis in H1-receptor knockout mice.
    Toftegaard CL; Knigge U; Kjaer A; Watanabe T; Friis-Hansen L; Warberg J
    Neuroimmunomodulation; 2002-2003; 10(6):344-50. PubMed ID: 12907841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis.
    Kariagina A; Zonis S; Afkhami M; Romanenko D; Chesnokova V
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E857-63. PubMed ID: 15985451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.